Skip to Main Content
Contribute Try STAT+ Today

Top of the morning to you. And a fine one it is. Crystal clear blue skies and deliciously cool breezes are greeting us today, which calls for a celebration with — you guessed it — a cup of stimulation. Our flavor of choice today is maple bourbon, for those keeping track. Despite the gorgeous weather, there is much to keep us in front of the laptop. This sounds familiar, yes? So time to get started with a few tidbits. Have a wonderful day, and drop us a line if you hear anything interesting …

Senior Democrats insist they have not given up the push to grant Medicare broad powers to negotiate lower drug prices, The New York Times writes. They know that the loss of the provision, promoted by President Biden on the campaign trail and in the White House, could be the single most embarrassing defeat in the package, since it has been central to Democratic congressional campaigns for nearly three decades. But with at least three House Democrats opposing the toughest version of the measure, and at least one Senate Democrat against it, government negotiating power appears almost certain to be curtailed, if not jettisoned.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Create a display name to comment

This name will appear with your comment